Dr. Andreas Roos wins Emerging Myologist of the Year Prize at WMS 2023

We are excited to congratulate Dr. Andreas Roos on winning the World Muscle Society’s (WMS) President’s Prize for Emerging Myologist of the Year!  

This award (formerly the President’s Prize for Young Myologist of the Year) recognizes outstanding contributions and innovation from an up-and-coming researcher in the field of myology. This year’s award highlights Dr. Roos’s exceptional portfolio of recent work, commending in particular his presentation at the conference on the identification of FILIP1 variants as a novel genetic cause for a neuropediatric disease with muscle involvement. Dr. Roos’s prolific output has resulted in a career total of almost 150 publications to date, and the FILIP1 manuscript is the latest of over 50 that Dr. Roos has published together with our group.  

Dr. Andreas Roos’s publication “Bi-allelic variants of FILIP1 cause congenital myopathy dysmorphism and neurological defects”

Dr. Roos is based at the Department of Neuropaediatrics of the Universitätsklinikum Essen in Germany and holds an adjunct professorship at uOttawa. He has been a long-time collaborator with our lab on joint projects on myotonic dystrophy, GNE myopathy, gene discovery and proteomic profiling in neuromuscular disease and has also consistently been involved in international research collaborations spanning a variety of diseases and techniques.

Congratulations Dr. Andreas Roos, World Muscle Society Emerging Myologist of the Year!

Dr. Andreas Roos receiving Emerging Myologist of the Year prize at World Muscle Society congress 2023.

Photo by World Muscle Society / World Muscle Society Congress 2023.

Dr. Andreas Roos receiving award on WMS 2023 stage, with text reading Congratulaions Dr. Andreas Roos, WMS President's Prize for Emerging Myologist of the Year 2023.

Read next...

text reding new clinical trial opportunities

New Clinical Trial Opportunities for Children and Adults in Ottawa

Our clinical research team is excited to share five new clinical trials activated across both pediatric and adult sites in Ottawa, CHEO and TOH. We...
Lochmüller Lab members gather for a group photo at the Ottawa NMD poster session.

Lochmüller Lab at Ottawa NMD 2023

This September 7th to 9th the University of Ottawa Éric Poulin Centre for Neuromuscular Disease (CNMD) hosted the 6th Ottawa International Conference on Neuromuscular Disease...
Figure from CMS study showing frequency of CMS-causing genes.

New Publication: Clinical and genetic characterisation of a large Indian congenital myasthenic syndrome cohort

Lochmüller Lab study identifying and genetically characterising the largest-ever Indian cohort of congenital myasthenic syndrome patients published in BRAIN: a journal of neurology. Congenital myasthenic syndromes...
The ProdGNE consortium posing in front of building.

Europe comes to Canada as Lochmüller Lab hosts the annual meeting of the ProDGNE consortium

This August we welcomed our international colleagues of the ProDGNE consortium to Ottawa as we hosted the annual meeting of ProDGNE, the three-year transnational pre-clinical...
K_OCONNOR_model_pic

New Publication: Bi-allelic variants of FILIP1 cause congenital myopathy, dysmorphism and neurological defects

Lochmüller Lab study on novel disease gene published in BRAIN: a journal of neurology. Filamin-A-interacting protein 1 (FILIP1) is a structural protein that is involved...
xr:d:DAFmd0iKQEo:9,j:7891826583529976397,t:23062115

NMD4C Receives Network Grant from CIHR-IMHA and Funding from MDC

We are excited to share that The Neuromuscular Disease Network for Canada (NMD4C) has received a network grant from the Canadian Institutes of Health Research...